Search
Close this search box.

Reilly Mach

Reilly Mach
Graduate Student, 2022-2023 Jack Satter / Skaggs Graduate Fellow

Miller Lab, Department of Chemistry
BA in Neuroscience & Psychology from Concordia College, Moorhead, MN
Keystone Symposium on Precision Genome Engineering
January 22-25, 2024, Banff, Alberta, Canada

Supporting Growth for Women in Science | Inaugural Travel Awards Notification

Scripps Research

Reilly Mach

Graduate Student, 2022-2023 Jack Satter / Skaggs Graduate Fellow

Conference Description:

The Keystone Symposium on Precision Genome Engineering will be held jointly with the symposium on Delivery of Nucleic Acid Therapeutics to generate discussion between these two important fields. This conference is well-known in the field for bringing together prominent leaders and experts in genetic engineering and biomolecule delivery. It serves as a platform for scientists, researchers and professionals working in various stages of genome editing to exchange knowledge, discuss the latest technological advancements, address emerging challenges and share progress in both preclinical and clinical applications. 

The Precision Genome Engineering conference aims to stimulate engaging discussions, facilitate knowledge exchange, and promote networking among participants. Through a series of presentations, workshops, panel discussions, and poster sessions, I will have the opportunity to learn from experts, showcase my own research findings, and establish valuable connections with peers and mentors in the scientific community. 

How will attending this conference add to your professional and scientific training?

Attending this conference offers numerous benefits to young women scientists like me. It provides a platform to present my own work, receive constructive feedback and gain exposure within the scientific community. Moreover, the event offers a unique opportunity for inspiration, empowerment and networking, enabling connections with like-minded professionals and establishment of collaborations that can significantly contribute to my education, professional training and overall career advancement. 

Especially coming from a primarily undergraduate liberal arts institution where research was not the main focus, I have previously had limited opportunities to attend conferences of the size and caliber of the Precision Genome Engineering conference. As a result, I have not yet had the chance to immerse myself in a large-scale scientific conference that brings together leading experts in the field. 

When choosing a graduate school, one of my top priorities was attending an institution that could provide the opportunity to participate in these research conferences, which I know is available at Scripps Research. Attending the Precision Genome Engineering conference will be a transformative experience for me, providing exposure to cutting-edge research, innovative technologies and networking opportunities that are vital for my professional growth. 

My research in the Miller Lab focuses on harnessing the potential of genome-editing techniques for CRISPR-mediated therapeutic applications, specifically working on using directed evolution of the Cas9 protein to accept fully chemically modified sgRNA. The Precision Genome Engineering conference will offer a comprehensive platform to expand my knowledge, explore new avenues of inquiry, and engage in discussions with leading experts in the field. 

Overall, attending the Precision Genome Engineering conference will enrich my graduate training by providing a dynamic learning environment, fostering collaborations and exposing me to the forefront of scientific advancements in the field of genome editing. The knowledge, experiences, and connections I gain from this conference will not only contribute to my current research but also shape my future career trajectory as a young scientist dedicated to advancing precision genetic medicine. 

“This conference will provide me with invaluable experiences, broaden my understanding of precision genome engineering, and inspire me to push the boundaries of scientific knowledge in the pursuit of developing innovative genetic medicines.”